CME Group Inc. (NASDAQ:CME) Shares Acquired by Coldstream Capital Management Inc.

Coldstream Capital Management Inc. increased its holdings in CME Group Inc. (NASDAQ:CMEFree Report) by 17.8% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,574 shares of the financial services provider’s stock after acquiring an additional 690 shares during the quarter. Coldstream Capital Management Inc.’s holdings in CME Group were worth $1,013,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of CME. Ameriprise Financial Inc. grew its stake in shares of CME Group by 11.3% in the 2nd quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider’s stock valued at $1,038,676,000 after purchasing an additional 537,758 shares during the last quarter. International Assets Investment Management LLC lifted its holdings in shares of CME Group by 21,465.5% during the third quarter. International Assets Investment Management LLC now owns 485,871 shares of the financial services provider’s stock worth $1,072,070,000 after purchasing an additional 483,618 shares during the period. Janus Henderson Group PLC grew its position in CME Group by 17.8% in the 3rd quarter. Janus Henderson Group PLC now owns 2,514,040 shares of the financial services provider’s stock valued at $554,707,000 after buying an additional 380,071 shares during the last quarter. Baillie Gifford & Co. acquired a new position in CME Group in the 3rd quarter valued at $79,692,000. Finally, Bank of Montreal Can increased its stake in CME Group by 41.8% in the 3rd quarter. Bank of Montreal Can now owns 1,028,090 shares of the financial services provider’s stock valued at $224,432,000 after buying an additional 303,169 shares during the period. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Analysts Set New Price Targets

Several analysts have recently weighed in on CME shares. Piper Sandler lifted their target price on shares of CME Group from $240.00 to $250.00 and gave the company an “overweight” rating in a report on Monday, October 28th. Oppenheimer lifted their price objective on CME Group from $245.00 to $258.00 and gave the company an “outperform” rating in a report on Thursday, October 24th. TD Cowen started coverage on CME Group in a research report on Thursday, September 26th. They set a “hold” rating and a $221.00 target price on the stock. Barclays raised their price target on CME Group from $231.00 to $257.00 and gave the company an “equal weight” rating in a report on Monday. Finally, Morgan Stanley upped their price objective on CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a report on Thursday, October 17th. Four investment analysts have rated the stock with a sell rating, seven have given a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $226.20.

Check Out Our Latest Stock Analysis on CME Group

CME Group Stock Performance

NASDAQ:CME opened at $235.95 on Friday. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.09. The company has a market capitalization of $85.03 billion, a P/E ratio of 24.73, a price-to-earnings-growth ratio of 5.52 and a beta of 0.56. The firm has a 50-day moving average price of $228.69 and a two-hundred day moving average price of $213.48. CME Group Inc. has a twelve month low of $190.70 and a twelve month high of $249.02.

CME Group (NASDAQ:CMEGet Free Report) last issued its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, topping analysts’ consensus estimates of $2.65 by $0.03. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The business had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.59 billion. During the same period last year, the company posted $2.25 EPS. The company’s revenue was up 18.4% on a year-over-year basis. As a group, research analysts expect that CME Group Inc. will post 10.22 earnings per share for the current fiscal year.

CME Group Increases Dividend

The business also recently disclosed a dividend, which will be paid on Thursday, January 16th. Stockholders of record on Friday, December 27th will be given a $5.80 dividend. This is an increase from CME Group’s previous dividend of $2.50. The ex-dividend date is Friday, December 27th. CME Group’s dividend payout ratio is currently 48.37%.

CME Group announced that its board has initiated a stock repurchase program on Thursday, December 5th that allows the company to buyback $3.00 billion in outstanding shares. This buyback authorization allows the financial services provider to buy up to 3.4% of its stock through open market purchases. Stock buyback programs are typically a sign that the company’s leadership believes its shares are undervalued.

Insider Activity at CME Group

In related news, Director Martin J. Gepsman sold 400 shares of the company’s stock in a transaction that occurred on Monday, November 4th. The shares were sold at an average price of $222.92, for a total transaction of $89,168.00. Following the transaction, the director now owns 25,067 shares of the company’s stock, valued at approximately $5,587,935.64. This represents a 1.57 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Sunil Cutinho sold 4,500 shares of CME Group stock in a transaction that occurred on Wednesday, October 30th. The stock was sold at an average price of $226.64, for a total transaction of $1,019,880.00. Following the completion of the sale, the insider now directly owns 27,053 shares of the company’s stock, valued at $6,131,291.92. The trade was a 14.26 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 8,028 shares of company stock valued at $1,811,681 over the last quarter. Insiders own 0.30% of the company’s stock.

About CME Group

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Read More

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.